Replies to post #332723 on Innovation Pharmaceuticals Inc (IPIX)

[steelyeye]

Brilacidin has worked successfully with humans in phase 2 trials and with three different indications. (Did you forget about these previous clinical trials as measure of why there is optimism about Brilacidin for C-19 in humans?)

So why not a fourth indication that has shown results in vitro that top what is currently available in terms of the SI number, and capacity to kill the virus in Lung, Kidney, and Vero cells?

By adding a little more context, the comparison with P fades.

I cannot imagine why it would not work in humans since it is going against the same virus it worked on in the lab.

neither can I